
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Serum and urinary biomarkers in lupus nephritis: do suPAR and VEGF play a role? - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE439789B6C3731B43970033A881DB.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jbrasnefro">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12165717/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Jornal Brasileiro de Nefrologia">
<meta name="citation_title" content="Serum and urinary biomarkers in lupus nephritis: do suPAR and VEGF play a role?">
<meta name="citation_author" content="Tamires Teixeira Piraciaba">
<meta name="citation_author_institution" content="Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brazil.">
<meta name="citation_author" content="Michelle Tiveron Passos Riguetti">
<meta name="citation_author_institution" content="Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brazil.">
<meta name="citation_author" content="Gianna Mastroianni Kirsztajn">
<meta name="citation_author_institution" content="Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brazil.">
<meta name="citation_publication_date" content="2025 Jun 13">
<meta name="citation_volume" content="47">
<meta name="citation_issue" content="4">
<meta name="citation_firstpage" content="e20240137">
<meta name="citation_doi" content="10.1590/2175-8239-JBN-2024-0137en">
<meta name="citation_pmid" content="40513062">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12165717/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12165717/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12165717/pdf/2175-8239-jbn-47-4-e20240137.pdf">
<meta name="description" content="The extent, activity, and effects of renal involvement in systemic lupus erythematosus are conditions difficult to diagnose and a renal biopsy is usually required for such purpose. Non-invasive methods are then of high interest to better understand ...">
<meta name="og:title" content="Serum and urinary biomarkers in lupus nephritis: do suPAR and VEGF play a role?">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The extent, activity, and effects of renal involvement in systemic lupus erythematosus are conditions difficult to diagnose and a renal biopsy is usually required for such purpose. Non-invasive methods are then of high interest to better understand ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12165717/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12165717">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1590/2175-8239-JBN-2024-0137en"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/2175-8239-jbn-47-4-e20240137.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12165717%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12165717/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12165717/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12165717/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jbrasnefro.gif" alt="Jornal Brasileiro de Nefrologia logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Jornal Brasileiro de Nefrologia" title="Link to Jornal Brasileiro de Nefrologia" shape="default" href="http://www.bjn.org.br/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Bras Nefrol</button></div>. 2025 Jun 13;47(4):e20240137. doi: <a href="https://doi.org/10.1590/2175-8239-JBN-2024-0137en" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1590/2175-8239-JBN-2024-0137en</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Bras%20Nefrol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Bras%20Nefrol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Bras%20Nefrol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Bras%20Nefrol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><div class="font-secondary font-xs">
<span>View full-text in </span><a href="#s1" class="text-primary">Portuguese</a>
</div>
<section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Serum and urinary biomarkers in lupus nephritis: do suPAR and VEGF play a role?</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Piraciaba%20TT%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Tamires Teixeira Piraciaba</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Tamires Teixeira Piraciaba</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brazil.</div>
<div>data collection and manuscript draft, interpretation of data, revision and approval of the final manuscript</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Piraciaba%20TT%22%5BAuthor%5D" class="usa-link"><span class="name western">Tamires Teixeira Piraciaba</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Riguetti%20MTP%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Michelle Tiveron Passos Riguetti</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Michelle Tiveron Passos Riguetti</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brazil.</div>
<div>conception of the study, interpretation of data, revision and approval of the final manuscript</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Riguetti%20MTP%22%5BAuthor%5D" class="usa-link"><span class="name western">Michelle Tiveron Passos Riguetti</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirsztajn%20GM%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Gianna Mastroianni Kirsztajn</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Gianna Mastroianni Kirsztajn</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brazil.</div>
<div>conception of the study, interpretation of data, revision and approval of the final manuscript</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirsztajn%20GM%22%5BAuthor%5D" class="usa-link"><span class="name western">Gianna Mastroianni Kirsztajn</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brazil.</div>
<div class="author-notes p">
<div class="fn" id="c001">
<sup>✉</sup><p class="display-inline">
<strong>Correspondence to:</strong> Gianna Mastroianni Kirsztajn. Email: <span>gm.kirsztajn@unifesp.br</span>
</p>
</div>
<div class="fn" id="fn1_pmc"><p><strong>Conflict of Interest:</strong> The authors declare no conflicts of interest.</p></div>
<div class="fn" id="fn1">
<p><strong>Editorial Responsibility:</strong> Editor-in-chief: Miguel C. Riella <a href="https://orcid.org/0000-0003-4181-613X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0003-4181-613X</a>
</p>
<p>Associate Editor: Lúcio Requião-Moura <a href="https://orcid.org/0000-0001-8751-9048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0001-8751-9048</a>
</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Tamires Teixeira Piraciaba</span></strong>: <span class="role">data collection and manuscript draft, interpretation of data, revision and approval of the final manuscript</span>
</div>
<div>
<strong class="contrib"><span class="name western">Michelle Tiveron Passos Riguetti</span></strong>: <span class="role">conception of the study, interpretation of data, revision and approval of the final manuscript</span>
</div>
<div>
<strong class="contrib"><span class="name western">Gianna Mastroianni Kirsztajn</span></strong>: <span class="role">conception of the study, interpretation of data, revision and approval of the final manuscript</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Jul 11; Accepted 2025 Apr 22; Collection date 2025 Oct-Dec.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12165717  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40513062/" class="usa-link">40513062</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Introduction:</h3>
<p>The extent, activity, and effects of renal involvement in systemic lupus erythematosus are conditions difficult to diagnose and a renal biopsy is usually required for such purpose. Non-invasive methods are then of high interest to better understand lupus nephritis (LN) features and prognosis. We have evaluated VEGF and suPAR levels as non-invasive biomarkers of disease activity in LN.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods:</h3>
<p>This cross-sectional study enrolled patients with LN aged 18 years or older of both genders who were assisted at the Outpatient Clinic of Glomerular Diseases of the Division of Nephrology of the Federal University of São Paulo (UNIFESP). Clinical renal histopathological characteristics, routine laboratory test profiles, and serum and urinary suPAR and serum VEGF of patients with LN were evaluated.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results:</h3>
<p>The sample consisted of 51 patients with LN, most of them females (88.2%), white (51.0%) with a mean age of 36.1 years (18 to 65 years), and a median disease duration of 2.5 years (1 month to 32 years). A positive correlation of urinary suPAR with SLEDAI-2K scores and hematuria was found. No significant correlation was found between serum VEGF and serum and urinary suPAR and proteinuria, serum creatinine, and urinary protein/creatinine ratio.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions:</h3>
<p>Serum suPAR and VEGF levels were not indicative of renal or general SLE activity, but our data suggest that urinary suPAR may be a useful biomarker of such conditions, as its levels have been shown to correlate with the presence of hematuria and with higher SLEDAI-2K scores.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Vascular Endothelial Growth Factor; suPAR; Lupus Erythematosus, Systemic; Lupus Nephritis; Hematuria; Proteinuria; Biomarkers</p></section></section><section id="sec5"><h2 class="pmc_sec_title">Introduction</h2>
<p>The extent, activity, and impact of renal involvement in systemic lupus erythematosus (SLE) are difficult to diagnose. No single clinical parameter or laboratory test defines such features, although some of them contribute to an adequate diagnosis. Given the complexity of the disease, an objective assessment using scores, such as the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), is useful to detect clinical changes, analyze new possible therapies, and guide the control of disease activity<a href="#B1" class="usa-link" aria-describedby="B1">
<sup>1</sup>
</a>.</p>
<p>Renal involvement occurs in about 60% of SLE patients<a href="#B2" class="usa-link" aria-describedby="B2">
<sup>2</sup>
</a> and kidney biopsy is the gold standard for diagnosis of lupus nephritis (LN). Because biopsy is an invasive procedure, noninvasive methods are of great interest to better establish LN features, including flares and prognosis<a href="#B3" class="usa-link" aria-describedby="B3">
<sup>3</sup>
</a>. An ideal biomarker for LN should reflect disease activity and histological classes, predict relapses, be easily measured, and enable early diagnosis of renal involvement<a href="#B4" class="usa-link" aria-describedby="B4">
<sup>4</sup>
</a>.</p>
<p>Among the biomarkers that were recently suggested as laboratory tools in the management of LN are vascular endothelial growth factor (VEGF) and soluble urokinase activating plasminogen receptor (suPAR).</p>
<p>VEGF is a biomarker produced by monocyte endothelial cells, macrophages, activated T cells, among other cells. Its production is increased as a response to inflammation, but its renal expression is reduced in patients with LN. Therefore, the role of VEGF is controversial and still needs to be elucidated<a href="#B5" class="usa-link" aria-describedby="B5">
<sup>5</sup>
</a>.</p>
<p>Many cytokine studies in SLE have focused on a limited number of markers. Adhya et al.<a href="#B6" class="usa-link" aria-describedby="B6">
<sup>6</sup>
</a> assessed a panel of six cytokines and concluded that tumor necrosis factor receptor 1 (TNF-R1) especially in serum but also in urine could be a useful marker along with serum VEGF and monocyte chemoattractant protein 1 (MCP-1), particularly for diagnosing active LN.</p>
<p>Urokinase activating plasminogen receptor (uPAR) is a membrane-bound protein present in several cells involved in the immune system (macrophages, monocytes, T lymphocytes)<a href="#B7" class="usa-link" aria-describedby="B7">
<sup>7</sup>
</a>. When dissociated from the cell surface, its soluble form (suPAR) is created. In podocytes, uPAR promotes cell contraction, fusion of podocyte processes, and proteinuria<a href="#B8" class="usa-link" aria-describedby="B8">
<sup>8</sup>
</a>, and has been described as an indicator of an activated immune system. This biomarker has been studied in different diseases<a href="#B9" class="usa-link" aria-describedby="B9">
<sup>9</sup>
</a> and its role needs to be better evaluated in LN.</p>
<p>Enocsson et al.<a href="#B10" class="usa-link" aria-describedby="B10">
<sup>10</sup>
</a> first demonstrated an association between serum suPAR levels and irreversible organ damage in SLE. Significantly higher suPAR levels were observed in patients with a higher Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) classification 2–5 years after their inclusion.</p>
<p>In the present study, we evaluated VEGF and suPAR levels as candidates for non-invasive biomarkers of disease activity in LN and assessed their association with traditional laboratory tests used to monitor disease activity in SLE and LN.</p></section><section id="sec6"><h2 class="pmc_sec_title">Methods</h2>
<section id="sec7"><h3 class="pmc_sec_title">Study Design, Working Definition, Clinical and Laboratory Assessments</h3>
<p>This prospective cross-sectional study enrolled adult patients with LN aged 18 years or older, of both genders, assisted at the Outpatient Clinic of Glomerular Diseases of the Division of Nephrology of the Federal University of São Paulo (UNIFESP).</p>
<p>Clinical, laboratory, and renal histopathological characteristics of the patients were evaluated, as well as routine laboratory tests used for patient follow-up. The study endpoints were serum VEGF and serum and urinary suPAR as markers of disease activity in individuals with LN. Both biomarkers were studied in the same urine and blood samples in which the routine tests were performed. SLEDAI-2K criteria were used for establishing LN activity scores.</p>
<p>SLE diagnosis was established according to the American Association of Rheumatology criteria<a href="#B11" class="usa-link" aria-describedby="B11">
<sup>11</sup>
</a>. Acute kidney injury (AKI) was defined according to serum creatinine elevation, i.e., increase of 1.5 to 1.9 times the baseline value over seven days or absolute increase of 0.3 mg/dL within 48 h, as proposed by KDIGO<a href="#B12" class="usa-link" aria-describedby="B12">
<sup>12</sup>
</a>.</p></section><section id="sec8"><h3 class="pmc_sec_title">Determination of VEGF</h3>
<p>VEGF levels were determined using the Quantikine<sup>®</sup> ELISA Human VEGF kit (cat. DVE00) according to the manufacturer’s instructions.</p>
<p>On the plate containing the solid phase and the VEGF monoclonal antibody, 100 µL of RD1W diluent, the standard curve, the controls (Immunoassay Control Group 1, R&amp;D Systems, cat. # QC01), and the samples per well were incubated for 2 h at room temperature.</p>
<p>Washings were performed and 200 µL of Human VEGF conjugate was added and incubated for 2 h at room temperature. The plate was then washed and 200 µL of the substrate solution was added and incubated for 25 min at room temperature. After the incubation period, the reaction was blocked by the addition of 50 µL of the stop solution.</p>
<p>The reaction reading was performed on a spectro­photometer (Titertek Multiskan, UNISCIENCE) at the 450 nm wavelength.</p></section><section id="sec9"><h3 class="pmc_sec_title">Determination of suPAR</h3>
<p>The determination of suPAR levels was performed using a commercial kit according to the manufacturer’s instructions.</p>
<p>To the plate containing the solid phase adsorbed with uPAR monoclonal antibody, 100 µL of the RD1W diluent, 50 µL of the standard, the controls (Immunoassay Control Group 4, R &amp; D Systems, cat. # QC21), and the samples were added, and the plate was incubated for 2 h at room temperature. Washings were performed and 200 µL of Human uPAR Conjugate was added and incubated for 2 h at room temperature. The plate was then washed and 200 µL of the substrate solution was added and incubated for 30 min at room temperature. After the incubation period, the reaction was blocked by the addition of 50 µL of the stop solution. The reaction reading was performed on a spectrophotometer (Titertek Multiskan, UNISCIENCE) at 450 nm wavelength.</p></section><section id="sec10"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>A descriptive statistical analysis was performed first, followed by inferential analyses, using Mann-Whitney (urinary and serum suPAR and serum VEGF vs. hematuria, anti-DNA and complement levels) and Kruskal-Wallis tests (urinary and serum suPAR and serum VEGF vs. proteinuria levels), and Spearman correlation (urinary and serum suPAR and serum VEGF according to the SLEDAI-2K scores). The significance level was established as p &lt; 0.05. Statistical analyses were performed using the statistics program R version 3.3.2.</p></section></section><section id="sec11"><h2 class="pmc_sec_title">Results</h2>
<p>The sample consisted of 51 patients with LN, most of them females (88.2%), white (51.0%), with a median age of 32 years, ranging from 18 to 65 years, and a median disease duration of 2.5 years, ranging from 1 month to 32 years (<a href="#T1" class="usa-link">Table 1</a>).</p>
<section class="tw xbox font-sm" id="T1"><h3 class="obj_head">Table 1. General characteristics of the patients with lupus nephritis.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5"><tbody>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Gender (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">female</td>
<td align="center" valign="top" rowspan="1" colspan="1">45</td>
<td align="center" valign="top" rowspan="1" colspan="1">88.2%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">male</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.8%</td>
</tr>
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">Race/ethnicity (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">white</td>
<td align="center" valign="top" rowspan="1" colspan="1">26</td>
<td align="center" valign="top" rowspan="1" colspan="1">51.0%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">black</td>
<td align="center" valign="top" rowspan="1" colspan="1">10</td>
<td align="center" valign="top" rowspan="1" colspan="1">19.6%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mixed (black+white)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">29.4%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Age (years) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">mean</td>
<td align="center" valign="top" rowspan="1" colspan="1">36.1</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">median</td>
<td align="center" valign="top" rowspan="1" colspan="1">32.0</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">minimum-maximum</td>
<td align="center" valign="top" rowspan="1" colspan="1">18–65</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">standard deviation</td>
<td align="center" valign="top" rowspan="1" colspan="1">12.2</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">LN classes (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">III</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.7%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">IV</td>
<td align="center" valign="top" rowspan="1" colspan="1">27</td>
<td align="center" valign="top" rowspan="1" colspan="1">53.0%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">V</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.4%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">unknown</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Time of disease (years) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">mean</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.72</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">median</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.50</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">minimum-maximum</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.08–32.00</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">standard deviation</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.46</td>
</tr>
<tr>
<td align="left" rowspan="5" valign="top" colspan="1">Immuno­suppressive drugs (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">CSA</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.0%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PRED</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.3%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">AZA+PRED</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">9.8%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">MYC+PRED</td>
<td align="center" valign="top" rowspan="1" colspan="1">25</td>
<td align="center" valign="top" rowspan="1" colspan="1">49.0%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">None</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.9%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Acute kidney injury (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">no</td>
<td align="center" valign="top" rowspan="1" colspan="1">44</td>
<td align="center" valign="top" rowspan="1" colspan="1">86.3%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">yes</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.7%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">SLEDAI-2K score (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">mean</td>
<td align="center" valign="top" rowspan="1" colspan="1">10.2</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">median</td>
<td align="center" valign="top" rowspan="1" colspan="1">11.0</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">minimum-maximum</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0–23.0</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">standard deviation</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.6</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3_pmc">
<p>Abbreviation – LN: lupus nephritis; AZA: azathioprine; CSA: cyclosporine; MYC: mycophenolate; PRED: prednisone.</p>
<p>Note – Most patients had LN classes IV (51.0%) and V (31.4%), predominantly without acute kidney injury (86.3%).</p>
</div></div></section><p>Routine laboratory results are shown in <a href="#T2" class="usa-link">Table 2</a>, and urinary suPAR, serum suPAR, and serum VEGF levels in <a href="#T3" class="usa-link">Table 3</a>.</p>
<section class="tw xbox font-sm" id="T2"><h3 class="obj_head">Table 2. Laboratory results of the patients with lupus nephritis.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5"><tbody>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Hematuria (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">yes</td>
<td align="center" valign="top" rowspan="1" colspan="1">28</td>
<td align="center" valign="top" rowspan="1" colspan="1">54.9%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">no</td>
<td align="center" valign="top" rowspan="1" colspan="1">23</td>
<td align="center" valign="top" rowspan="1" colspan="1">45.1%</td>
</tr>
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">Proteinuria (g/24h) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 1</td>
<td align="center" valign="top" rowspan="1" colspan="1">23</td>
<td align="center" valign="top" rowspan="1" colspan="1">45.1%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">1–3.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">11</td>
<td align="center" valign="top" rowspan="1" colspan="1">21.6%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">&gt; 3.5</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.3%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Proteinuria (g/24h) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">mean</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.50</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">median</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.05</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">minimum-maximum</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.00–9.49</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">standard deviation</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.64</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Anti-DNA (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">positive</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.3%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">negative</td>
<td align="center" valign="top" rowspan="1" colspan="1">34</td>
<td align="center" valign="top" rowspan="1" colspan="1">66.7%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Complement (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">normal</td>
<td align="center" valign="top" rowspan="1" colspan="1">35</td>
<td align="center" valign="top" rowspan="1" colspan="1">68.6%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">low</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">31.4%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Serum albumin (g/dL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">normal</td>
<td align="center" valign="top" rowspan="1" colspan="1">34</td>
<td align="center" valign="top" rowspan="1" colspan="1">66.7%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">low</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">33.3%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Serum creatinine (mg/dL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 1.2 (normal)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36</td>
<td align="center" valign="top" rowspan="1" colspan="1">70.6%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">≥ 1.2</td>
<td align="center" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">29.4%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Serum creatinine (mg/dL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">mean</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.26</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">median</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.97</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">minimum-maximum</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.43–4.88</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">standard deviation</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.98</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">uPCR (g/g) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.15 (normal)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">13.7%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">≥ 0.15</td>
<td align="center" valign="top" rowspan="1" colspan="1">44</td>
<td align="center" valign="top" rowspan="1" colspan="1">86.3%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">uPCR (g/g) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">mean</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.05</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">median</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.04</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">minimum-maximum</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.00–9.69</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">standard deviation</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.46</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn4"><p>Abbreviation – uPCR: urinary protein/creatinine ratio.</p></div></div></section><section class="tw xbox font-sm" id="T3"><h3 class="obj_head">Table 3. Urinary and serum supar and serum vegf levels of patients with lupus nephritis.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5"><tbody>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Urinary suPAR (pg/mL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">mean</td>
<td align="center" valign="top" rowspan="1" colspan="1">3445.01</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">median</td>
<td align="center" valign="top" rowspan="1" colspan="1">2687.70</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">minimum-maximum</td>
<td align="center" valign="top" rowspan="1" colspan="1">453.40–12440.23</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">standard deviation</td>
<td align="center" valign="top" rowspan="1" colspan="1">2612.49</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Serum VEGF (pg/mL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">mean</td>
<td align="center" valign="top" rowspan="1" colspan="1">303.97</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">median</td>
<td align="center" valign="top" rowspan="1" colspan="1">225.37</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">minimum-maximum</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.26–1261.13</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">standard deviation</td>
<td align="center" valign="top" rowspan="1" colspan="1">297.13</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Serum suPAR (pg/mL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">mean</td>
<td align="center" valign="top" rowspan="1" colspan="1">3525.23</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">median</td>
<td align="center" valign="top" rowspan="1" colspan="1">3098.19</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">minimum-maximum</td>
<td align="center" valign="top" rowspan="1" colspan="1">1326.30–14591.21</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">standard deviation</td>
<td align="center" valign="top" rowspan="1" colspan="1">2137.21</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/T3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>It was found that 28 (54.9%) patients had glomerular hematuria characterized by the presence of a dysmorphic pattern of red cells in urine. Proteinuria levels above 3.5 g/24 h were observed in 17 (33.3%) patients.</p>
<p>Negative anti-DNA and normal serum albumin were confirmed in 34 (66.7%) patients. Of the total, 16 (31.4%) patients exhibited complement consumption (serum levels of C3 and/or C4 below the normal reference range).</p>
<p>The association of the three biomarkers (urinary suPAR, VEGF, and serum suPAR) with hematuria, 24-hour proteinuria, positivity for anti-DNA antibodies, serum complement levels, serum creatinine, urine protein/creatinine ratio, and SLEDAI-2K scores was evaluated. Inferential results confirmed that patients with glomerular hematuria had higher urinary suPAR levels compared to those without hematuria (p = 0.003). For VEGF (p = 0.219) and serum suPAR (p = 0.623), there was a negative association that was not statistically significant.</p>
<p>There was no association between proteinuria levels and urinary suPAR (p = 0.631), VEGF (p = 0.727), and serum suPAR (p = 0.561). Although patients with positive anti-DNA showed lower urinary suPAR (p = 0.936), VEGF (p = 0.424), and serum suPAR (p = 0.328) compared to those with negative anti-DNA, this was not statistically significant. Categories of serum creatinine and the protein/creatinine ratio were not associated with suPAR and VEGF levels.</p>
<p>We confirmed a positive correlation between SLEDAI-2K and urinary suPAR (Spearman correlation coefficient r = 0.347; p = 0.012, <a href="#F1" class="usa-link">Figure 1</a>), and also between glomerular hematuria and urinary suPAR (r = 0.322; p = 0.021). The higher the SLEDAI-2K and hematuria counts, the higher the urinary suPAR levels.</p>
<figure class="fig xbox font-sm" id="F1"><h3 class="obj_head">Figure 1. Bidimensional dispersion diagram between urinary suPAR (pg/mL) and SLEDAI-2K scores in patients with lupus nephritis.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12165717_2175-8239-jbn-47-4-e20240137-gf01.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef1/12165717/07ea6edd2748/2175-8239-jbn-47-4-e20240137-gf01.jpg" loading="lazy" height="730" width="800" alt="Figure 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>No significant association was found between serum VEGF and urinary suPAR (r = −0.197; p = 0.165), proteinuria (r = −0.187; p = 0.188), serum creatinine (r = 0.034; p = 0.814), and urinary protein/creatinine ratio (r = −0.220; p = 0.121).</p>
<p>The same occurred when investigating potential associations between serum suPAR and SLEDAI-2K (r = 0.055; p = 0.699), 24-hour proteinuria levels (r = 0.154; p = 0.280), and the protein/creatinine ratio (r = 0.253; p = 0.073). Higher levels of serum creatinine were associated with greater levels of serum suPAR (r = 0.511; p &lt; 0.001).</p></section><section id="sec12"><h2 class="pmc_sec_title">DISCUSSION</h2>
<p>Lupus nephritis is one of the most severe manifestations of SLE, leading to a high disease morbidity and mortality. The assessment of kidney injury activity and severity is important for a better follow-up of the patients. This study aimed to evaluate the profile of suPAR and VEGF in patients with LN and their eventual association with disease activity in SLE and LN.</p>
<p>The sample of the LN population here evaluated consisted of 51 patients, 88.2% female, with an average age of 36.1 years. These characteristics are similar to those of other studies. Satirapoj et al.<a href="#B13" class="usa-link" aria-describedby="B13">
<sup>13</sup>
</a> studied 68 Asian patients with a predominance of females (97.1%) and with a mean age of 31.7 years. In 2017, a Brazilian study analyzed 8,761 causes of death in which SLE was recorded as the underlying disease. In that study, 90.7% of the sample were women, 49.2% were white, and the age range was 20 to 39 years<a href="#B14" class="usa-link" aria-describedby="B14">
<sup>14</sup>
</a>.</p>
<p>The race/ethnicity of the subjects is difficult to classify in Brazil due to the high miscegenation of the population. Nevertheless, based on the assigned race of the patients in the medical records, 51% were white, a similar percentage to that of the last study cited<a href="#B14" class="usa-link" aria-describedby="B14">
<sup>14</sup>
</a>.</p>
<p>In our service, LN patients are usually submitted to kidney biopsy when they present with more prominent urinary abnormalities and/or renal dysfunction at presentation and/or do not respond to immunosuppressive treatment during follow-up. Regarding the histological diagnosis, there was a predominance of patients with class IV LN (51%), followed by class V LN (31.4%). Class IV is the histological pattern associated with more severe LN, as reported by other studies<sup>
<a href="#B13" class="usa-link" aria-describedby="B13">13</a>, <a href="#B15" class="usa-link" aria-describedby="B15">15</a>, <a href="#B16" class="usa-link" aria-describedby="B16">16</a>
</sup>. It is worth noting that our study was performed in a tertiary care hospital that receives patients from all over the country, often referred for severe and complex conditions, which in part justifies the predominance of such a presentation. Although LN class IV was the predominant histological class, only a minority of these patients (13.7%) had AKI at some point in the course of the disease.</p>
<p>Women with class IV and moderate activity predominated in the study population (according to SLEDAI-2K). SLEDAI-2K is a modification of the original SLEDAI, and both are indicators of mortality in SLE and are used to measure disease activity and assess the need for treatment initiation<a href="#B17" class="usa-link" aria-describedby="B17">
<sup>17</sup>
</a>.</p>
<p>In this study, a positive and increasing correlation was found between SLEDAI-2K scores and urinary suPAR levels (the higher the score, the higher the urinary biomarker values), but not with serum suPAR and VEGF levels.</p>
<p>In our population, the anti-DNA antibody test was positive in 33.3% and hypocomplementemia (decreased C3 or C4) occurred in 31.4% of the patients. Complement levels and anti-DNA reactivity were not correlated with suPAR or VEGF levels. It is known that positive or increasing anti-DNA antibody titers and hypocomplementemia, especially low C3 levels, are indicative of renal activity, but these findings are neither essential nor sufficient for such diagnosis<a href="#B18" class="usa-link" aria-describedby="B18">
<sup>18</sup>
</a>.</p>
<p>Glomerular hematuria alone is an important urinary abnormality in the diagnosis and follow-up of patients with LN and in this study, hematuria was present in 54.9% of the patients by the time of the samples collection. Although often associated with renal activity, hematuria does not always predict active disease in LN<a href="#B19" class="usa-link" aria-describedby="B19">
<sup>19</sup>
</a>, and additional tests are needed to establish renal involvement due to LN. Concurrent elevated urinary suPAR and hematuria would reinforce renal activity secondary to SLE.</p>
<p>In the evaluation of 87 subjects with LN, a significant correlation was found between active LN and urinary VEGF, but not serum VEGF levels<a href="#B6" class="usa-link" aria-describedby="B6">
<sup>6</sup>
</a>.</p>
<p>The biomarkers here evaluated have also been studied in other glomerulopathies, such as focal segmental glomerulosclerosis. Li et al.<a href="#B20" class="usa-link" aria-describedby="B20">
<sup>20</sup>
</a> evaluated serum suPAR in 109 individuals and observed that its levels were significantly higher in patients with such disease than in healthy subjects or in patients with minimal change disease or with membranous nephropathy.</p>
<p>In the present study, we evaluated traditional and new laboratory biomarkers in patients with LN. There was no association between serum suPAR and VEGF levels and renal or general SLE activity, but urinary levels of suPAR correlated with the presence of glomerular hematuria and with higher SLEDAI-2K scores, i.e. with LN and SLE activity.</p>
<p>Limitations of this study include the peculiarities of the Brazilian ethnicity that could be related to polymorphisms of the VEGF gene and susceptibility to SLE. We did not evaluate subgroups of patients according to time of disease, types of treatment, biopsy findings, and other parameters, because a higher number of patients would be necessary to compose representative subgroups. Besides, although patients were recruited early in the course of the disease, with a mean of 2.5 years from diagnosis to inclusion in the study, different lengths of time on antimalarials and/or immunosuppressants may have an impact on the results.</p>
<p>There are few studies investigating the role of suPAR and VEGF in glomerular diseases, particularly in LN. These initial results suggest a potential role for urinary suPAR as a biomarker that could reflect LN and SLE activity, which could be used as an additional tool in clinical practice and is available for laboratory determination in an easily collected urine sample.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>TTP and GMK received research grants from CNPq (National Council for Scientific and Technological Development) – Brazil. This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), finance code 001.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), finance code 001.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="FN1"><p><strong>Funding:</strong> This work was supported by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), finance code 001.</p></div></div></section><section id="sec13"><h2 class="pmc_sec_title">Data availability</h2>
<p>Data that are not presented here and corroborate the results of this study will be available upon request to the corresponding author.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1">
<span class="label">1.</span><cite>Castrejón I, Tani C, Jolly M, Huang A, Mosca M. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care. Clin Exp Rheumatol. 2014;32(5, Suppl 85):S-85–S-95.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/25365095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Exp%20Rheumatol&amp;title=Indices%20to%20assess%20patients%20with%20systemic%20lupus%20erythematosus%20in%20clinical%20trials,%20long-term%20observational%20studies,%20and%20clinical%20care&amp;author=I%20Castrej%C3%B3n&amp;author=C%20Tani&amp;author=M%20Jolly&amp;author=A%20Huang&amp;author=M%20Mosca&amp;volume=32&amp;issue=5,%20Suppl%2085&amp;publication_year=2014&amp;pages=S-85-S-95&amp;pmid=25365095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2">
<span class="label">2.</span><cite>Klumb EM, Silva CA, Lanna CC, Sato EI, Borba EF, Brenol JC, et al.  Consenso da Sociedade Brasileira de Reumatologia para o diagnóstico, manejo e tratamento da nefrite lúpica. Rev Bras Reumatol. 2015;55(1):1–21. doi: 10.1016/j.rbr.2014.09.008.</cite> [<a href="https://doi.org/10.1016/j.rbr.2014.09.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25595733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rev%20Bras%20Reumatol&amp;title=Consenso%20da%20Sociedade%20Brasileira%20de%20Reumatologia%20para%20o%20diagn%C3%B3stico,%20manejo%20e%20tratamento%20da%20nefrite%20l%C3%BApica&amp;author=EM%20Klumb&amp;author=CA%20Silva&amp;author=CC%20Lanna&amp;author=EI%20Sato&amp;author=EF%20Borba&amp;volume=55&amp;issue=1&amp;publication_year=2015&amp;pages=1-21&amp;pmid=25595733&amp;doi=10.1016/j.rbr.2014.09.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3">
<span class="label">3.</span><cite>Edelbauer M, Kshirsagar S, Riedl M, Billing H, Tönshoff B, Haffner D, et al.  Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis. Pediatr Nephrol. 2012;27(5):793–800. doi: 10.1007/s00467-011-2062-z.</cite> [<a href="https://doi.org/10.1007/s00467-011-2062-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22147121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Nephrol&amp;title=Soluble%20VEGF%20receptor%201%20promotes%20endothelial%20injury%20in%20children%20and%20adolescents%20with%20lupus%20nephritis&amp;author=M%20Edelbauer&amp;author=S%20Kshirsagar&amp;author=M%20Riedl&amp;author=H%20Billing&amp;author=B%20T%C3%B6nshoff&amp;volume=27&amp;issue=5&amp;publication_year=2012&amp;pages=793-800&amp;pmid=22147121&amp;doi=10.1007/s00467-011-2062-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4">
<span class="label">4.</span><cite>Vasarhelyi B, Toldi G, Balog A. The clinical value of soluble urokinase plasminogen activator receptor (suPAR) levels in autoimmune connective tissue disorders. EJIFCC. 2016;27(2):122–129.</cite> [<a href="/articles/PMC4975228/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27683525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EJIFCC&amp;title=The%20clinical%20value%20of%20soluble%20urokinase%20plasminogen%20activator%20receptor%20(suPAR)%20levels%20in%20autoimmune%20connective%20tissue%20disorders&amp;author=B%20Vasarhelyi&amp;author=G%20Toldi&amp;author=A%20Balog&amp;volume=27&amp;issue=2&amp;publication_year=2016&amp;pages=122-129&amp;pmid=27683525&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5">
<span class="label">5.</span><cite>Edelbauer M, Kshirsagar S, Riedl M, Billing H, Tönshoff B, Haffner D, et al.  Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis. Pediatr Nephrol. 2012;27(5):793–800. doi: 10.1007/s00467-011-2062-z.</cite> [<a href="https://doi.org/10.1007/s00467-011-2062-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22147121/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr%20Nephrol&amp;title=Soluble%20VEGF%20receptor%201%20promotes%20endothelial%20injury%20in%20children%20and%20adolescents%20with%20lupus%20nephritis&amp;author=M%20Edelbauer&amp;author=S%20Kshirsagar&amp;author=M%20Riedl&amp;author=H%20Billing&amp;author=B%20T%C3%B6nshoff&amp;volume=27&amp;issue=5&amp;publication_year=2012&amp;pages=793-800&amp;pmid=22147121&amp;doi=10.1007/s00467-011-2062-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6">
<span class="label">6.</span><cite>Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Lupus. 2019;28(6):713–721. doi: 10.1177/0961203319845487.</cite> [<a href="https://doi.org/10.1177/0961203319845487" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31046570/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lupus&amp;title=Soluble%20TNF-R1,%20VEGF%20and%20other%20cytokines%20as%20markers%20of%20disease%20activity%20in%20systemic%20lupus%20erythematosus%20and%20lupus%20nephritis&amp;author=Z%20Adhya&amp;author=M%20El%20Anbari&amp;author=S%20Anwar&amp;author=A%20Mortimer&amp;author=N%20Marr&amp;volume=28&amp;issue=6&amp;publication_year=2019&amp;pages=713-721&amp;pmid=31046570&amp;doi=10.1177/0961203319845487&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7">
<span class="label">7.</span><cite>Kronbichler A, Saleem MA, Meijers B, Shin JI. Soluble urokinase receptors in focal segmental glomerulosclerosis: a review on the scientific point of view. J Immunol Res. 2016;2016:2068691. doi: 10.1155/2016/2068691.</cite> [<a href="https://doi.org/10.1155/2016/2068691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4967695/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27504461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunol%20Res&amp;title=Soluble%20urokinase%20receptors%20in%20focal%20segmental%20glomerulosclerosis:%20a%20review%20on%20the%20scientific%20point%20of%20view&amp;author=A%20Kronbichler&amp;author=MA%20Saleem&amp;author=B%20Meijers&amp;author=JI%20Shin&amp;volume=2016&amp;publication_year=2016&amp;pages=2068691&amp;pmid=27504461&amp;doi=10.1155/2016/2068691&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8">
<span class="label">8.</span><cite>Alapati K, Gopinath S, Malla RR, Dasari VR, Rao JS. uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton of glioma-initiating cells. Int J Oncol. 2012;41(2):599–610. doi: 10.3892/ijo.2012.1496.</cite> [<a href="https://doi.org/10.3892/ijo.2012.1496" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3482985/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22641287/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Oncol&amp;title=uPAR%20and%20cathepsin%20B%20knockdown%20inhibits%20radiation-induced%20PKC%20integrated%20integrin%20signaling%20to%20the%20cytoskeleton%20of%20glioma-initiating%20cells&amp;author=K%20Alapati&amp;author=S%20Gopinath&amp;author=RR%20Malla&amp;author=VR%20Dasari&amp;author=JS%20Rao&amp;volume=41&amp;issue=2&amp;publication_year=2012&amp;pages=599-610&amp;pmid=22641287&amp;doi=10.3892/ijo.2012.1496&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9">
<span class="label">9.</span><cite>Guthoff M, Wagner R, Randrianarisoa E, Hatziagelaki E, Peter A, Haring H, et al.  Soluble urokinase receptor (suPAR) predicts microalbuminuria in patients at risk for type 2 diabetes mellitus. Sci Rep. 2017;7(1):40627. doi: 10.1038/srep40627.</cite> [<a href="https://doi.org/10.1038/srep40627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5238426/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28091558/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Soluble%20urokinase%20receptor%20(suPAR)%20predicts%20microalbuminuria%20in%20patients%20at%20risk%20for%20type%202%20diabetes%20mellitus&amp;author=M%20Guthoff&amp;author=R%20Wagner&amp;author=E%20Randrianarisoa&amp;author=E%20Hatziagelaki&amp;author=A%20Peter&amp;volume=7&amp;issue=1&amp;publication_year=2017&amp;pages=40627&amp;pmid=28091558&amp;doi=10.1038/srep40627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10">
<span class="label">10.</span><cite>Enocsson H, Wettero J, Skogh T, Sjowall C. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus. Transl Res. 2013;162(5):287–296. doi: 10.1016/j.trsl.2013.07.003.</cite> [<a href="https://doi.org/10.1016/j.trsl.2013.07.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23916811/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transl%20Res&amp;title=Soluble%20urokinase%20plasminogen%20activator%20receptor%20levels%20reflect%20organ%20damage%20in%20systemic%20lupus%20erythematosus&amp;author=H%20Enocsson&amp;author=J%20Wettero&amp;author=T%20Skogh&amp;author=C%20Sjowall&amp;volume=162&amp;issue=5&amp;publication_year=2013&amp;pages=287-296&amp;pmid=23916811&amp;doi=10.1016/j.trsl.2013.07.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11">
<span class="label">11.</span><cite>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. doi: 10.1002/art.1780400928.</cite> [<a href="https://doi.org/10.1002/art.1780400928" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9324032/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis%20Rheum&amp;title=Updating%20the%20American%20College%20of%20Rheumatology%20revised%20criteria%20for%20the%20classification%20of%20systemic%20lupus%20erythematosus&amp;author=MC%20Hochberg&amp;volume=40&amp;issue=9&amp;publication_year=1997&amp;pages=1725&amp;pmid=9324032&amp;doi=10.1002/art.1780400928&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12">
<span class="label">12.</span><cite>KDIGO AKI Workgroup  KDIGO clinical practice guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2:1–138.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int%20Suppl&amp;title=KDIGO%20clinical%20practice%20guideline%20for%20Acute%20Kidney%20Injury&amp;volume=2&amp;publication_year=2012&amp;pages=1-138&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13">
<span class="label">13.</span><cite>Satirapoj B, Kitiyakara C, Leelahavanichkul A, Avihingsanon Y, Supasyndh O. Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis. BMC Nephrol. 2017;18(1):263. doi: 10.1186/s12882-017-0678-3.</cite> [<a href="https://doi.org/10.1186/s12882-017-0678-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5545009/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28778196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Nephrol&amp;title=Urine%20neutrophil%20gelatinase-associated%20lipocalin%20to%20predict%20renal%20response%20after%20induction%20therapy%20in%20active%20lupus%20nephritis&amp;author=B%20Satirapoj&amp;author=C%20Kitiyakara&amp;author=A%20Leelahavanichkul&amp;author=Y%20Avihingsanon&amp;author=O%20Supasyndh&amp;volume=18&amp;issue=1&amp;publication_year=2017&amp;pages=263&amp;pmid=28778196&amp;doi=10.1186/s12882-017-0678-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14">
<span class="label">14.</span><cite>Costi LR, Iwamoto HM, Neves DCO, Caldas CAM. Mortalidade por lúpus eritematoso sistêmico no Brasil: avaliação das causas de acordo com o banco de dados de saúde do governo. Rev Bras Reumatol. 2017;57(6):574–582. doi: 10.1016/j.rbr.2017.05.007.</cite> [<a href="https://doi.org/10.1016/j.rbr.2017.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29032927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rev%20Bras%20Reumatol&amp;title=Mortalidade%20por%20l%C3%BApus%20eritematoso%20sist%C3%AAmico%20no%20Brasil:%20avalia%C3%A7%C3%A3o%20das%20causas%20de%20acordo%20com%20o%20banco%20de%20dados%20de%20sa%C3%BAde%20do%20governo&amp;author=LR%20Costi&amp;author=HM%20Iwamoto&amp;author=DCO%20Neves&amp;author=CAM%20Caldas&amp;volume=57&amp;issue=6&amp;publication_year=2017&amp;pages=574-582&amp;pmid=29032927&amp;doi=10.1016/j.rbr.2017.05.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15">
<span class="label">15.</span><cite>Olson SW, Lee JJ, Prince LK, Baker TP, Papadopoulos P, Edison J, et al.  Elevated subclinical double-stranded DNA antibodies and future proliferative lupus nephritis. Clin J Am Soc Nephrol. 2013;8(10):1702–1708. doi: 10.2215/CJN.01910213.</cite> [<a href="https://doi.org/10.2215/CJN.01910213" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3789337/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23833315/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20J%20Am%20Soc%20Nephrol&amp;title=Elevated%20subclinical%20double-stranded%20DNA%20antibodies%20and%20future%20proliferative%20lupus%20nephritis&amp;author=SW%20Olson&amp;author=JJ%20Lee&amp;author=LK%20Prince&amp;author=TP%20Baker&amp;author=P%20Papadopoulos&amp;volume=8&amp;issue=10&amp;publication_year=2013&amp;pages=1702-1708&amp;pmid=23833315&amp;doi=10.2215/CJN.01910213&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16">
<span class="label">16.</span><cite>Rijnink EC, Teng YKO, Wilhelmus S, Almekinders M, Wolterbeek R, Cransberg K, et al.  Clinical and histopathologic characteristics associated with renal outcomes in lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):734–743. doi: 10.2215/CJN.10601016.</cite> [<a href="https://doi.org/10.2215/CJN.10601016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5477219/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28473317/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20J%20Am%20Soc%20Nephrol&amp;title=Clinical%20and%20histopathologic%20characteristics%20associated%20with%20renal%20outcomes%20in%20lupus%20nephritis&amp;author=EC%20Rijnink&amp;author=YKO%20Teng&amp;author=S%20Wilhelmus&amp;author=M%20Almekinders&amp;author=R%20Wolterbeek&amp;volume=12&amp;issue=5&amp;publication_year=2017&amp;pages=734-743&amp;pmid=28473317&amp;doi=10.2215/CJN.10601016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17">
<span class="label">17.</span><cite>Mikdashi J, Nived O. Measuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical research. Arthritis Res Ther. 2015;17(1):183. doi: 10.1186/s13075-015-0702-6.</cite> [<a href="https://doi.org/10.1186/s13075-015-0702-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4507322/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26189728/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis%20Res%20Ther&amp;title=Measuring%20disease%20activity%20in%20adults%20with%20systemic%20lupus%20erythematosus:%20the%20challenges%20of%20administrative%20burden%20and%20responsiveness%20to%20patient%20concerns%20in%20clinical%20research&amp;author=J%20Mikdashi&amp;author=O%20Nived&amp;volume=17&amp;issue=1&amp;publication_year=2015&amp;pages=183&amp;pmid=26189728&amp;doi=10.1186/s13075-015-0702-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18">
<span class="label">18.</span><cite>Misra R, Gupta RB. Biomarkers in lupus nephritis. Int J Rheum Dis. 2015;18(2):219–232. doi: 10.1111/1756-185X.12602.</cite> [<a href="https://doi.org/10.1111/1756-185X.12602" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25884459/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Rheum%20Dis&amp;title=Biomarkers%20in%20lupus%20nephritis&amp;author=R%20Misra&amp;author=RB%20Gupta&amp;volume=18&amp;issue=2&amp;publication_year=2015&amp;pages=219-232&amp;pmid=25884459&amp;doi=10.1111/1756-185X.12602&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19">
<span class="label">19.</span><cite>Mittal BV, Pendse S, Rennke HG, Singh AK. Hematuria in a patient with class IV lupus nephritis. Kidney Int. 2006;70(6):1182–1186. doi: 10.1038/sj.ki.5001730.</cite> [<a href="https://doi.org/10.1038/sj.ki.5001730" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16871238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Kidney%20Int&amp;title=Hematuria%20in%20a%20patient%20with%20class%20IV%20lupus%20nephritis&amp;author=BV%20Mittal&amp;author=S%20Pendse&amp;author=HG%20Rennke&amp;author=AK%20Singh&amp;volume=70&amp;issue=6&amp;publication_year=2006&amp;pages=1182-1186&amp;pmid=16871238&amp;doi=10.1038/sj.ki.5001730&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20">
<span class="label">20.</span><cite>Li F, Zheng C, Zhong Y, Zeng C, Xu F, Yin R, et al.  Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS. Clin J Am Soc Nephrol. 2014;9(11):1903–1911. doi: 10.2215/CJN.02370314.</cite> [<a href="https://doi.org/10.2215/CJN.02370314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4220753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25318750/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20J%20Am%20Soc%20Nephrol&amp;title=Relationship%20between%20serum%20soluble%20urokinase%20plasminogen%20activator%20receptor%20level%20and%20steroid%20responsiveness%20in%20FSGS&amp;author=F%20Li&amp;author=C%20Zheng&amp;author=Y%20Zhong&amp;author=C%20Zeng&amp;author=F%20Xu&amp;volume=9&amp;issue=11&amp;publication_year=2014&amp;pages=1903-1911&amp;pmid=25318750&amp;doi=10.2215/CJN.02370314&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section></section><article class="sub-article" lang="pt" id="s1"><section class="pmc-layout__citation font-secondary font-xs"><div>J Bras Nefrol. 2025 Jun 13;47(4):e20240137. [Article in Portuguese] doi: <a href="https://doi.org/10.1590/2175-8239-JBN-2024-0137pt" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1590/2175-8239-JBN-2024-0137pt</a>
</div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Biomarcadores séricos e urinários na nefrite lúpica: qual o papel do suPAR e do VEGF?</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Piraciaba%20TT%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Tamires Teixeira Piraciaba</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Tamires Teixeira Piraciaba</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brasil.</div>
<div>coleta de dados e redação do manuscrito, interpretação dos dados, revisão e aprovação do manuscrito final</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Piraciaba%20TT%22%5BAuthor%5D" class="usa-link"><span class="name western">Tamires Teixeira Piraciaba</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Riguetti%20MTP%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Michelle Tiveron Passos Riguetti</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Michelle Tiveron Passos Riguetti</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brasil.</div>
<div>análise laboratorial, interpretação dos dados, revisão e aprovação do manuscrito final</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Riguetti%20MTP%22%5BAuthor%5D" class="usa-link"><span class="name western">Michelle Tiveron Passos Riguetti</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirsztajn%20GM%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Gianna Mastroianni Kirsztajn</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Gianna Mastroianni Kirsztajn</span></h3>
<div class="p">
<sup>1</sup>Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brasil.</div>
<div>concepção do estudo, interpretação dos dados, revisão e aprovação do manuscrito final</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kirsztajn%20GM%22%5BAuthor%5D" class="usa-link"><span class="name western">Gianna Mastroianni Kirsztajn</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a.c" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a.c" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a.c" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a.c" class="d-panel p" style="display: none">
<div class="p" id="aff2">
<sup>1</sup>Universidade Federal de São Paulo, Departamento de Medicina, São Paulo, SP, Brasil.</div>
<div class="author-notes p">
<div class="fn" id="c002">
<sup>✉</sup><p class="display-inline">
<strong>Correspondência para:</strong> Gianna Mastroianni Kirsztajn. Email: <span>gm.kirsztajn@unifesp.br</span>
</p>
</div>
<div class="fn" id="fn6"><p><strong>Conflito de Interesses:</strong> Os autores declaram não haver conflito de interesses.</p></div>
<div class="fn" id="fn3">
<p><strong>Responsabilidade Editorial:</strong> Editor-chefe: Miguel C. Riella <a href="https://orcid.org/0000-0003-4181-613X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0003-4181-613X</a>
</p>
<p>Editor Associado: Lúcio Requião-Moura <a href="https://orcid.org/0000-0001-8751-9048" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://orcid.org/0000-0001-8751-9048</a>
</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Tamires Teixeira Piraciaba</span></strong>: <span class="role">coleta de dados e redação do manuscrito, interpretação dos dados, revisão e aprovação do manuscrito final</span>
</div>
<div>
<strong class="contrib"><span class="name western">Michelle Tiveron Passos Riguetti</span></strong>: <span class="role">análise laboratorial, interpretação dos dados, revisão e aprovação do manuscrito final</span>
</div>
<div>
<strong class="contrib"><span class="name western">Gianna Mastroianni Kirsztajn</span></strong>: <span class="role">concepção do estudo, interpretação dos dados, revisão e aprovação do manuscrito final</span>
</div>
</div>
<div id="anp_a.c" class="d-panel p" style="display: none"><div class="notes p"><section id="historyfront-stub1" class="history"><p>Collection date 2025 Oct-Dec.</p></section></div></div>
<div id="clp_a.c" class="d-panel p" style="display: none"><div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div></div>
</div>
<div></div>
</div></section><section class="body sub-article-body"><section class="abstract" id="abstract2"><h2>Resumo</h2>
<section id="sec14"><h3 class="pmc_sec_title">Introdução:</h3>
<p>A extensão, atividade e efeitos do acometimento renal no lúpus eritematoso sistêmico são condições de difícil diagnóstico, sendo geralmente necessária biópsia renal para tal fim. Métodos não invasivos despertam, portanto, grande interesse para uma melhor compreensão das características e prognóstico da nefrite lúpica (NL). Avaliamos os níveis de VEGF e suPAR como biomarcadores não invasivos da atividade da doença na NL.</p></section><section id="sec15"><h3 class="pmc_sec_title">Métodos:</h3>
<p>Este estudo transversal envolveu pacientes com NL, de ambos os sexos, com 18 anos ou mais, atendidos no Ambulatório de Glomerulopatias da Disciplina de Nefrologia da Universidade Federal de São Paulo (UNIFESP). Foram avaliadas características clínicas e histopatológicas renais, perfis de exames laboratoriais de rotina, suPAR sérico e urinário e VEGF sérico de pacientes com NL.</p></section><section id="sec16"><h3 class="pmc_sec_title">Resultados:</h3>
<p>A amostra consistiu em 51 pacientes com NL, a maioria do sexo feminino (88,2%), brancos (51,0%) com idade média de 36,1 anos (18 a 65 anos) e duração mediana da doença de 2,5 anos (1 mês a 32 anos). Foi encontrada uma correlação positiva entre suPAR urinário e escores SLEDAI-2K e hematúria. Não foi observada correlação significativa entre VEGF sérico e suPAR sérico e urinário e proteinúria, creatinina sérica e relação P/C urinária.</p></section><section id="sec17"><h3 class="pmc_sec_title">Conclusões:</h3>
<p>Os níveis séricos de suPAR e VEGF não foram indicativos de atividade renal ou geral do LES, mas nossos dados sugerem que o suPAR urinário pode ser um biomarcador útil para tais condições, uma vez que seus níveis demonstraram correlacionar-se com a presença de hematúria e com escores SLEDAI-2K mais elevados.</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Descritores:</strong> Fator de Crescimento do Endotélio Vascular, suPAR, Lúpus Eritematoso Sistêmico, Nefrite Lúpica, Hematúria, Proteinúria, Biomarcadores</p></section></section><section id="sec18"><h2 class="pmc_sec_title">Introdução</h2>
<p>A extensão, a atividade e o impacto do acometi­mento renal no lúpus eritematoso sistêmico (LES) são difíceis de diagnosticar. Nenhum parâmetro clínico ou exame laboratorial isolado define essas características, embora alguns deles contribuam para um diagnóstico adequado. Dada a complexidade da doença, uma avaliação objetiva utilizando escores, como o Índice de Atividade da Doença do Lúpus Eritematoso Sistêmico (SLEDAI, na sigla em inglês), é útil para detectar alterações clínicas, analisar novas possíveis terapias e orientar o controle da atividade da doença<a href="#B1" class="usa-link" aria-describedby="B1">
<sup>1</sup>
</a>.</p>
<p>O acometimento renal ocorre em cerca de 60% dos pacientes com LES<a href="#B2" class="usa-link" aria-describedby="B2">
<sup>2</sup>
</a> e a biópsia renal é o padrão-ouro para o diagnóstico de nefrite lúpica (NL). Como a biópsia é um procedimento invasivo, métodos não invasivos são de grande interesse para melhor estabelecer as características da NL, incluindo surtos e prognóstico<a href="#B3" class="usa-link" aria-describedby="B3">
<sup>3</sup>
</a>. Um biomarcador ideal para a NL deve refletir a atividade da doença e as classes histológicas, prever recidivas, ser facilmente mensurável e permitir o diagnóstico precoce do acometimento renal<a href="#B4" class="usa-link" aria-describedby="B4">
<sup>4</sup>
</a>.</p>
<p>Entre os biomarcadores recentemente sugeridos como ferramentas laboratoriais no manejo da NL estão o fator de crescimento endotelial vascular (VEGF) e o receptor do ativador de plasminogênio tipo uroquinase solúvel (suPAR).</p>
<p>O VEGF é um biomarcador produzido por células endoteliais, monócitos, macrófagos, células T ativadas, entre outras células. Sua produção é aumentada em resposta à inflamação, mas sua expressão renal é reduzida em pacientes com NL. Portanto, o papel do VEGF é controverso e ainda precisa ser elucidado<a href="#B5" class="usa-link" aria-describedby="B5">
<sup>5</sup>
</a>.</p>
<p>Muitos estudos sobre citocinas no LES têm-se concentrado em um número limitado de marcadores. Adhya et al.<a href="#B6" class="usa-link" aria-describedby="B6">
<sup>6</sup>
</a> avaliaram um painel de seis citocinas e concluíram que o receptor 1 do fator de necrose tumoral (TNF-R1), especialmente no soro, mas também na urina, pode ser um marcador útil, juntamente com o VEGF sérico e a proteína quimiotática de monócitos-1 (MCP-1), particularmente para o diagnóstico de NL ativa.</p>
<p>O receptor do ativador de plasminogênio tipo uroquinase (uPAR) é uma proteína ligada à membrana presente em diversas células envolvidas no sistema imunológico (macrófagos, monócitos, linfócitos T)<a href="#B7" class="usa-link" aria-describedby="B7">
<sup>7</sup>
</a>. Quando dissociada da superfície celular, dá origem à sua forma solúvel (suPAR). Nos podócitos, o uPAR promove a contração celular, a fusão dos processos podocitários e a proteinúria<a href="#B8" class="usa-link" aria-describedby="B8">
<sup>8</sup>
</a>, e foi descrito como um indicador de ativação do sistema imunológico. Este biomarcador tem sido estudado em diferentes doenças<a href="#B9" class="usa-link" aria-describedby="B9">
<sup>9</sup>
</a> e seu papel precisa ser melhor avaliado na NL.</p>
<p>Enocsson et al.<a href="#B10" class="usa-link" aria-describedby="B10">
<sup>10</sup>
</a> foram os primeiros a demonstrar uma associação entre os níveis séricos de suPAR e danos irreversíveis aos órgãos no LES. Níveis significativamente mais elevados de suPAR foram observados em pacientes com uma classificação mais elevada no Índice de Danos (SDI) do Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) entre 2 e 5 anos após sua inclusão.</p>
<p>No presente estudo, avaliamos os níveis de VEGF e suPAR como candidatos a biomarcadores não invasivos da atividade da doença na NL e avaliamos sua associação com testes laboratoriais tradicionais utilizados para monitorar a atividade da doença no LES e na NL.</p></section><section id="sec19"><h2 class="pmc_sec_title">Métodos</h2>
<section id="sec20"><h3 class="pmc_sec_title">Desenho do Estudo, Definição do Trabalho, Avaliações Clínicas e Laboratoriais</h3>
<p>Este estudo transversal prospectivo incluiu pacientes adultos com NL com idade igual ou superior a 18 anos, de ambos os sexos, atendidos no Ambulatório de Glomerulopatias da Disciplina de Nefrologia da Universidade Federal de São Paulo (UNIFESP).</p>
<p>Foram avaliadas as características clínicas, labo­ratoriais e histopatológicas renais dos pacientes, bem como os exames laboratoriais de rotina utilizados no acompanhamento clínico. Os desfechos do estudo foram os níveis séricos de VEGF e os níveis séricos e urinários de suPAR como marcadores da ativi­dade da doença em indivíduos com NL. Ambos os biomarcadores foram analisados nas mesmas amostras de urina e sangue em que foram realizados os testes de rotina. Os critérios do SLEDAI-2K foram empregados para estabelecer os escores de atividade da NL.</p>
<p>O diagnóstico de LES foi estabelecido de acordo com os critérios da American Association of Rheumatology<a href="#B11" class="usa-link" aria-describedby="B11">
<sup>11</sup>
</a>. A injúria renal aguda (IRA) foi definida com base na elevação da creatinina sérica, ou seja, aumento de 1,5 a 1,9 vezes o valor basal em sete dias ou aumento absoluto de 0,3 mg/dL em 48 horas, conforme proposto pelo KDIGO<a href="#B12" class="usa-link" aria-describedby="B12">
<sup>12</sup>
</a>.</p></section><section id="sec21"><h3 class="pmc_sec_title">Determinação do VEGF</h3>
<p>Os níveis de VEGF foram determinados utilizando o kit Quantikine<sup>®</sup> ELISA Human VEGF (cat. DVE00) conforme as instruções do fabricante.</p>
<p>Na placa contendo a fase sólida e o anticorpo monoclonal VEGF, foram incubados, por 2 horas em temperatura ambiente, 100 µL de diluente RD1W, a curva padrão, os controles (Immunoassay Control Group 1, R&amp;D Systems, cat. # QC01) e as amostras por poço.</p>
<p>Foram realizadas lavagens e 200 µL de conjugado de VEGF humano foram adicionados e incubados por 2 h em temperatura ambiente. A placa foi então lavada e 200 µL da solução de substrato foram adicionados e incubados por 25 minutos em temperatura ambiente. Após o período de incubação, a reação foi bloqueada pela adição de 50 µL de solução de parada.</p>
<p>A leitura da reação foi realizada em um espec­trofotômetro (Titertek Multiskan, UNISCIENCE) no comprimento de onda de 450 nm.</p></section><section id="sec22"><h3 class="pmc_sec_title">Determinação do suPAR</h3>
<p>A determinação dos níveis de suPAR foi realizada usando um kit comercial de acordo com as instruções do fabricante.</p>
<p>Na placa contendo a fase sólida adsorvida com o anticorpo monoclonal anti-uPAR, foram adicionados 100 µL do diluente RD1W, 50 µL do padrão, os controles (Immunoassay Control Group 4, R &amp; D Systems, cat. # QC21) e as amostras. A placa foi incubada por 2 h em temperatura ambiente. Foram realizadas lavagens e, em seguida, 200 µL de conjugado de uPAR humano foram adicionados e incubados por 2 h em temperatura ambiente. A placa foi então lavada e 200 µL da solução de substrato foram adicionados e incubados por 30 minutos em temperatura ambiente. Após o período de incubação, a reação foi bloqueada pela adição de 50 µL de solução de parada. A leitura da reação foi realizada em um espectrofotômetro (Titertek Multiskan, UNISCIENCE) no comprimento de onda de 450 nm.</p></section><section id="sec23"><h3 class="pmc_sec_title">Análise Estatística</h3>
<p>Primeiramente, foi realizada uma análise estatística descritiva, seguida de análises inferenciais, utilizando os testes de Mann-Whitney (suPAR urinário e sérico e VEGF sérico vs. níveis de hematúria, anti-DNA e de complemento) e Kruskal-Wallis (suPAR urinário e sérico e VEGF sérico vs. níveis de proteinúria), além da correlação de Spearman (suPAR urinário e sérico e VEGF sérico de acordo com os escores SLEDAI-2K). O nível de significância foi estabelecido como p &lt; 0,05. As análises estatísticas foram realizadas utilizando o programa estatístico R versão 3.3.2.</p></section></section><section id="sec24"><h2 class="pmc_sec_title">Resultados</h2>
<p>A amostra foi composta por 51 pacientes com NL, a maioria do sexo feminino (88,2%), brancos (51,0%), com idade mediana de 32 anos, variando de 18 a 65 anos, e duração mediana da doença de 2,5 anos, com variação de 1 mês a 32 anos (<a href="#T4" class="usa-link">Tabela 1</a>).</p>
<section class="tw xbox font-sm" id="T4"><h3 class="obj_head">Tabela 1. Características gerais dos pacientes com nefrite lúpica.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5"><tbody>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Sexo (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">feminino</td>
<td align="center" valign="top" rowspan="1" colspan="1">45</td>
<td align="center" valign="top" rowspan="1" colspan="1">88,2%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">masculino</td>
<td align="center" valign="top" rowspan="1" colspan="1">6</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,8%</td>
</tr>
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">Raça/etnia (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">brancos</td>
<td align="center" valign="top" rowspan="1" colspan="1">26</td>
<td align="center" valign="top" rowspan="1" colspan="1">51,0%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">pretos</td>
<td align="center" valign="top" rowspan="1" colspan="1">10</td>
<td align="center" valign="top" rowspan="1" colspan="1">19,6%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">miscigenados (pretos+brancos)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">29,4%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Idade (anos) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">média</td>
<td align="center" valign="top" rowspan="1" colspan="1">36,1</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mediana</td>
<td align="center" valign="top" rowspan="1" colspan="1">32,0</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mínimo-máximo</td>
<td align="center" valign="top" rowspan="1" colspan="1">18–65</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desvio-padrão</td>
<td align="center" valign="top" rowspan="1" colspan="1">12,2</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Classes de NL (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">III</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">13,7%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">IV</td>
<td align="center" valign="top" rowspan="1" colspan="1">27</td>
<td align="center" valign="top" rowspan="1" colspan="1">53,0%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">V</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">31,4%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desconhecida</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,0%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Duração da doença (anos) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">média</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,72</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mediana</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,50</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mínimo-máximo</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,08–32,00</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desvio-padrão</td>
<td align="center" valign="top" rowspan="1" colspan="1">7,46</td>
</tr>
<tr>
<td align="left" rowspan="5" valign="top" colspan="1">Medicamentos imunos­supressores (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">CSA</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,0%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">PRED</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">33,3%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">AZA+PRED</td>
<td align="center" valign="top" rowspan="1" colspan="1">5</td>
<td align="center" valign="top" rowspan="1" colspan="1">9,8%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">MYC+PRED</td>
<td align="center" valign="top" rowspan="1" colspan="1">25</td>
<td align="center" valign="top" rowspan="1" colspan="1">49,0%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">Nenhum</td>
<td align="center" valign="top" rowspan="1" colspan="1">3</td>
<td align="center" valign="top" rowspan="1" colspan="1">5,9%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Injúria renal aguda (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">não</td>
<td align="center" valign="top" rowspan="1" colspan="1">44</td>
<td align="center" valign="top" rowspan="1" colspan="1">86,3%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">sim</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">13,7%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Score SLEDAI-2K (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">média</td>
<td align="center" valign="top" rowspan="1" colspan="1">10,2</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mediana</td>
<td align="center" valign="top" rowspan="1" colspan="1">11,0</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mínimo-máximo</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,0–23,0</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desvio-padrão </td>
<td align="center" valign="top" rowspan="1" colspan="1">5,6</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/T4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="fn8"><p>Abreviações – NL: nefrite lúpica; AZA: azatioprina; CSA: ciclosporina; MYC: micofenolato; PRED: prednisona.</p></div>
<div class="fn" id="fn9"><p>Nota – A maioria dos pacientes apresentou NL classes IV (51,0%) e V (31,4%), predominantemente sem injúria renal aguda (86,3%).</p></div>
</div></section><p>Os resultados laboratoriais de rotina são apresentados na <a href="#T5" class="usa-link">Tabela 2</a>, e os níveis de suPAR urinário, suPAR sérico e VEGF sérico, na <a href="#T6" class="usa-link">Tabela 3</a>.</p>
<section class="tw xbox font-sm" id="T5"><h3 class="obj_head">Tabela 2. Resultados laboratoriais dos pacientes com nefrite lúpica.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5"><tbody>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Hematúria (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">sim</td>
<td align="center" valign="top" rowspan="1" colspan="1">28</td>
<td align="center" valign="top" rowspan="1" colspan="1">54,9%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">não</td>
<td align="center" valign="top" rowspan="1" colspan="1">23</td>
<td align="center" valign="top" rowspan="1" colspan="1">45,1%</td>
</tr>
<tr>
<td align="left" rowspan="3" valign="top" colspan="1">Proteinúria (g/24h) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 1</td>
<td align="center" valign="top" rowspan="1" colspan="1">23</td>
<td align="center" valign="top" rowspan="1" colspan="1">45,1%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">1–3,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">11</td>
<td align="center" valign="top" rowspan="1" colspan="1">21,6%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">&gt; 3,5</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">33,3%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Proteinúria (g/24h) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">média</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,50</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mediana</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,05</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mínimo-máximo</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,00–9,49</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desvio-padrão</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,64</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Anti-DNA (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">positivo</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">33,3%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">negativo</td>
<td align="center" valign="top" rowspan="1" colspan="1">34</td>
<td align="center" valign="top" rowspan="1" colspan="1">66,7%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Complemento (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">normal</td>
<td align="center" valign="top" rowspan="1" colspan="1">35</td>
<td align="center" valign="top" rowspan="1" colspan="1">68,6%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">baixo</td>
<td align="center" valign="top" rowspan="1" colspan="1">16</td>
<td align="center" valign="top" rowspan="1" colspan="1">31,4%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Albumina sérica (g/dL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">normal</td>
<td align="center" valign="top" rowspan="1" colspan="1">34</td>
<td align="center" valign="top" rowspan="1" colspan="1">66,7%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">baixa</td>
<td align="center" valign="top" rowspan="1" colspan="1">17</td>
<td align="center" valign="top" rowspan="1" colspan="1">33,3%</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">Creatinina sérica (mg/dL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 1,2 (normal)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36</td>
<td align="center" valign="top" rowspan="1" colspan="1">70,6%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">≥ 1,2</td>
<td align="center" valign="top" rowspan="1" colspan="1">15</td>
<td align="center" valign="top" rowspan="1" colspan="1">29,4%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">Creatinina sérica (mg/dL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">média</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,26</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mediana</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,97</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mínimo-máximo</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,43–4,88</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desvio-padrão</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,98</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">RPCU (g/g) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0,15 (normal)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7</td>
<td align="center" valign="top" rowspan="1" colspan="1">13,7%</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">≥ 0,15</td>
<td align="center" valign="top" rowspan="1" colspan="1">44</td>
<td align="center" valign="top" rowspan="1" colspan="1">86,3%</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">RPCU (g/g) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">média</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,05</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mediana</td>
<td align="center" valign="top" rowspan="1" colspan="1">1,04</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mínimo-máximo</td>
<td align="center" valign="top" rowspan="1" colspan="1">0,00–9,69</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desvio-padrão</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,46</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/T5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn10"><p>Abreviação – RPCU: relação proteína/creatinina urinária.</p></div></div></section><section class="tw xbox font-sm" id="T6"><h3 class="obj_head">Tabela 3. Níveis de supar urinário e sérico e vegf sérico de pacientes com nefrite lúpica.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups" cellpadding="5" cellspacing="5"><tbody>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">suPAR urinário (pg/mL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">média</td>
<td align="center" valign="top" rowspan="1" colspan="1">3445,01</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mediana</td>
<td align="center" valign="top" rowspan="1" colspan="1">2687,70</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mínimo-máximo</td>
<td align="center" valign="top" rowspan="1" colspan="1">453,40–12440,23</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desvio-padrão</td>
<td align="center" valign="top" rowspan="1" colspan="1">2612,49</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">VEGF sérico (pg/mL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">média</td>
<td align="center" valign="top" rowspan="1" colspan="1">303,97</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mediana</td>
<td align="center" valign="top" rowspan="1" colspan="1">225,37</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mínimo-máximo</td>
<td align="center" valign="top" rowspan="1" colspan="1">2,26–1261,13</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desvio-padrão</td>
<td align="center" valign="top" rowspan="1" colspan="1">297,13</td>
</tr>
<tr>
<td align="left" rowspan="4" valign="top" colspan="1">suPAR sérico (pg/mL) (n = 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">média</td>
<td align="center" valign="top" rowspan="1" colspan="1">3525,23</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mediana</td>
<td align="center" valign="top" rowspan="1" colspan="1">3098,19</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">mínimo-máximo</td>
<td align="center" valign="top" rowspan="1" colspan="1">1326,30–14591,21</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">desvio-padrão</td>
<td align="center" valign="top" rowspan="1" colspan="1">2137,21</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/T6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Verificou-se que 28 (54,9%) pacientes apres­entaram hematúria glomerular caracterizada pela presença de dismorfismo eritrocitário. Níveis de proteinúria superiores a 3,5 g/24 h foram observados em 17 (33,3%) pacientes.</p>
<p>O anti-DNA negativo e níveis normais de albumina sérica foram confirmados em 34 (66,7%) pacientes. Do total, 16 (31,4%) pacientes apresentaram consumo de complemento (níveis séricos de C3 e/ou C4 abaixo da faixa de referência de normalidade).</p>
<p>Avaliou-se a associação dos três biomarcadores (suPAR urinário, VEGF e suPAR sérico) com hematúria, proteinúria de 24 horas, positividade para anticorpos anti-DNA, níveis séricos de complemento, creatinina sérica, relação proteína/creatinina urinária e escores SLEDAI-2K. Os resultados inferenciais confirmaram que pacientes com hematúria glomerular apresentaram níveis mais elevados de suPAR urinário em comparação com aqueles sem hematúria (p = 0,003). Já para VEGF (p = 0,219) e suPAR sérico (p = 0,623), houve uma associação negativa, sem significância estatística.</p>
<p>Não houve associação entre níveis de proteinúria e suPAR urinário (p = 0,631), VEGF (p = 0,727) e suPAR sérico (p = 0,561). Embora os pacientes com anti-DNA positivo tenham apresentado níveis mais baixos de suPAR urinário (p = 0,936), VEGF (p = 0,424) e suPAR sérico (p = 0,328) em comparação com aqueles com anti-DNA negativo, esse resultado não foi estatisticamente significante. As categorias de creatinina sérica e a relação proteína/creatinina não foram associadas aos níveis de suPAR e VEGF.</p>
<p>Confirmamos uma correlação positiva entre SLEDAI-2K e suPAR urinário (coeficiente de correlação de Spearman r = 0,347; p = 0,012, <a href="#F2" class="usa-link">Figura 1</a>), e também entre hematúria glomerular e suPAR urinário (r = 0,322; p = 0,021). Quanto maior os índices de SLEDAI-2K e hematúria, maiores os níveis de suPAR urinário.</p>
<figure class="fig xbox font-sm" id="F2"><h3 class="obj_head">Figura 1. Diagrama de dispersão bidimensional entre suPAR urinário (pg/mL) e escores SLEDAI-2K em pacientes com nefrite lúpica.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12165717_2175-8239-jbn-47-4-e20240137-gf02.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef1/12165717/07ea6edd2748/2175-8239-jbn-47-4-e20240137-gf02.jpg" loading="lazy" height="730" width="800" alt="Figura 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>Não foi encontrada associação estatisticamente significante entre VEGF sérico e suPAR urinário (r = −0,197; p = 0,165), proteinúria (r = −0,187; p = 0,188), creatinina sérica (r = 0,034; p = 0,814) e relação proteína/creatinina urinária (r = −0,220; p = 0,121).</p>
<p>O mesmo ocorreu ao investigar possíveis associações entre o suPAR sérico e o SLEDAI-2K (r = 0,055; p = 0,699), os níveis de proteinúria de 24 horas (r = 0,154; p = 0,280) e a relação proteína/creatinina (r = 0,253; p = 0,073). Níveis mais elevados de creatinina sérica foram associados a níveis mais altos de suPAR sérico (r = 0,511; p &lt; 0,001).</p></section><section id="sec25"><h2 class="pmc_sec_title">Discussão</h2>
<p>A nefrite lúpica é uma das manifestações mais graves do LES, resultando em alta morbidade e mortalidade. A avaliação da atividade e da gravidade da injúria renal é importante para um melhor acompanhamento dos pacientes. Este estudo teve como objetivo avaliar o perfil de suPAR e VEGF em pacientes com NL e sua eventual associação com a atividade da doença no LES e na própria NL.</p>
<p>A amostra da população com NL aqui avaliada consistiu em 51 pacientes, sendo 88,2% do sexo feminino, com idade média de 36,1 anos. Essas características são semelhantes às encontradas em outros estudos. Satirapoj et al.<a href="#B13" class="usa-link" aria-describedby="B13">
<sup>13</sup>
</a> estudaram 68 pacientes asiáticos com predominância do sexo feminino (97,1%) e idade média de 31,7 anos. Em 2017, um estudo brasileiro analisou 8.761 causas de óbito nas quais o LES foi registrado como doença subjacente. Nesse estudo, 90,7% dos participantes corresponderam a mulheres, na faixa etária foi de 20 a 39 anos, e 49,2% eram brancos<a href="#B14" class="usa-link" aria-describedby="B14">
<sup>14</sup>
</a>.</p>
<p>A classificação racial/étnica dos indivíduos no Brasil é dificultada pela elevada miscigenação da população. No entanto, com base na raça atribuída aos pacientes nos prontuários médicos, 51% foram considerados brancos, uma porcentagem semelhante à do último estudo citado<a href="#B14" class="usa-link" aria-describedby="B14">
<sup>14</sup>
</a>.</p>
<p>Em nosso serviço, os pacientes com NL são geralmente submetidos à biópsia renal quando apresentam anormalidades urinárias mais proeminentes e/ou disfunção renal no momento da apresentação e/ou não respondem ao tratamento imunossupressor durante o acompanhamento. Com relação ao diagnóstico histológico, houve uma predominância de pacientes com NL classe IV (51%), seguidos por NL classe V (31,4%). A classe IV representa o padrão histológico associado às formas mais graves de NL, conforme relatado por outros autores<sup>
<a href="#B13" class="usa-link" aria-describedby="B13">13</a>, <a href="#B15" class="usa-link" aria-describedby="B15">15</a>, <a href="#B16" class="usa-link" aria-describedby="B16">16</a>
</sup>. Vale ressaltar que nosso estudo foi realizado em um hospital de cuidados terciários que recebe pacientes de todo o país, muitas vezes encaminhados por apresentarem condições graves e complexas, o que em parte justifica a predominância dessa apresentação. Embora a classe IV da NL tenha sido a classe histológica predominante, somente uma minoria desses pacientes (13,7%) apresentou IRA em algum momento do curso da doença.</p>
<p>Houve predominância de mulheres com NL classe IV e de atividade moderada na população do estudo (de acordo com o SLEDAI-2K). O SLEDAI-2K é uma modificação do SLEDAI original e ambos são usados como indicadores de mortalidade no LES, além de serem utilizados para mensurar a atividade da doença e avaliar a necessidade de início do tratamento<a href="#B17" class="usa-link" aria-describedby="B17">
<sup>17</sup>
</a>.</p>
<p>Neste estudo, observou-se uma correlação positiva e crescente entre os escores do SLEDAI-2K e os níveis de suPAR urinário (quanto maior o escore, maiores os valores do biomarcador urinário), mas o mesmo não ocorreu com os níveis séricos de suPAR e VEGF.</p>
<p>Em nossa população, o teste para anticorpos anti-DNA foi positivo em 33,3% e a hipocomplementemia (redução de C3 ou C4) ocorreu em 31,4% dos pacientes. Os níveis de complemento e a positividade para anti-DNA não apresentaram correlação com os níveis de suPAR ou VEGF. Sabe-se que títulos positivos ou crescentes de anticorpos anti-DNA e hipocomplementemia, especialmente níveis reduzidos de C3, são indicativos de atividade renal; porém, esses achados não são essenciais nem suficientes para tal diagnóstico<a href="#B18" class="usa-link" aria-describedby="B18">
<sup>18</sup>
</a>.</p>
<p>A hematúria glomerular isolada é uma anormalidade urinária importante no diagnóstico e acompanhamento de pacientes com NL e, neste estudo, a hematúria esteve presente em 54,9% dos pacientes no momento da coleta das amostras. Embora frequentemente associada à atividade renal, a hematúria nem sempre prediz doença ativa na NL<a href="#B19" class="usa-link" aria-describedby="B19">
<sup>19</sup>
</a>, e testes adicionais são necessários para estabelecer o acometimento renal decorrente da NL. A concomitância de suPAR urinário elevado e hematúria reforçaria a atividade renal secundária ao LES.</p>
<p>Na avaliação de 87 indivíduos com NL, foi encontrada uma correlação significante entre NL ativa e VEGF urinário, mas não com os níveis séricos de VEGF<a href="#B6" class="usa-link" aria-describedby="B6">
<sup>6</sup>
</a>.</p>
<p>Os biomarcadores aqui avaliados também foram estudados em outras glomerulopatias, como a glomeruloesclerose segmentar e focal. Li et al.<a href="#B20" class="usa-link" aria-describedby="B20">
<sup>20</sup>
</a> avaliaram o suPAR sérico em 109 indivíduos e observaram que seus níveis foram significantemente mais elevados em pacientes com essa doença em relação a indivíduos saudáveis ou a pacientes com doença de lesões mínimas ou nefropatia membranosa.</p>
<p>No presente estudo, avaliamos biomarcadores laboratoriais tradicionais e novos em pacientes com NL. Não houve associação entre os níveis séricos de suPAR e VEGF e a atividade renal ou geral do LES, mas os níveis urinários de suPAR se correlacionaram com a presença de hematúria glomerular e com escores SLEDAI-2K mais elevados, ou seja, com a atividade da NL e do LES.</p>
<p>As limitações deste estudo incluem as peculiaridades da etnia brasileira que podem estar relacionadas a polimorfismos do gene VEGF e à suscetibilidade ao LES. Não foram avaliados subgrupos de pacientes de acordo com a duração da doença, tipos de tratamento, achados de biópsia renal e outros parâmetros, uma vez que seria necessário um número maior de pacientes para compor subgrupos representativos. Além disso, embora os pacientes tenham sido recrutados no início do curso da doença, com uma média de 2,5 anos desde o diagnóstico até a inclusão no estudo, diferentes períodos sob o uso de antimaláricos e/ou imunossupressores podem ter impactado os resultados.</p>
<p>Existem poucos estudos que investigam o papel do suPAR e do VEGF em doenças glomerulares, particularmente na NL. Esses resultados iniciais sugerem um potencial papel para o suPAR urinário como um biomarcador capaz de refletir a atividade da NL e do LES, que pode ser utilizado como uma ferramenta adicional na prática clínica, e é dosado em uma amostra de urina de fácil obtenção.</p></section><section id="ack2" class="ack"><h2 class="pmc_sec_title">Agradecimentos</h2>
<p>TTP e GMK receberam bolsas de pesquisa do CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico) – Brasil. Este trabalho contou com o apoio da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), código de financiamento 001.</p></section><section id="fn-group2" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="FN2"><p><strong>Financiamento:</strong> Este trabalho contou com o apoio da Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), código de financiamento 001.</p></div></div></section><section id="sec26"><h2 class="pmc_sec_title">Disponibilidade de Dados</h2>
<p>Os dados que não foram apresentados aqui e que corroboram os resultados deste estudo estarão disponíveis mediante solicitação ao autor correspondente.</p></section></section></article><article class="sub-article" id="_ad93_"><section class="pmc-layout__citation font-secondary font-xs"><div></div></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Associated Data</h1></hgroup><ul class="d-buttons inline-list"></ul>
<div class="d-panels font-secondary-light"></div>
<div></div>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
</div></section><section class="body sub-article-body"><section id="_adda93_" lang="en" class="data-availability-statement"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data that are not presented here and corroborate the results of this study will be available upon request to the corresponding author.</p>
<p>Os dados que não foram apresentados aqui e que corroboram os resultados deste estudo estarão disponíveis mediante solicitação ao autor correspondente.</p></section></section></article><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Jornal Brasileiro de Nefrologia are provided here courtesy of <strong>Sociedade Brasileira de Nefrologia</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1590/2175-8239-JBN-2024-0137en"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/2175-8239-jbn-47-4-e20240137.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (294.7 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12165717/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12165717/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12165717%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12165717/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12165717/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12165717/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40513062/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12165717/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40513062/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12165717/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12165717/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="4zurW3KnSxsD7soadouJhNkfQYXYnP8WRvQdjZ2S41B4da8Xmi3J51DGctl5Y6Yd">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
    

    </body>
</html>
